ANIMAL CANCER FOUNDATION

Uniting Pet & Human Research for a Cause®

aka ACF   |   Port Washington, NY   |  www.acfoundation.org

Mission

Animal Cancer Foundation is dedicated to finding a cure for cancer by funding research in and increasing public awareness of comparative oncology, the study of naturally occurring cancers in human beings and companion animals.

Ruling year info

1999

Executive Director

Ms. Barbara S Cohen

President

Ms. Annie Selkovits Taylor

Main address

191 Main Street #225

Port Washington, NY 11050 USA

Show more contact info

EIN

94-3342838

NTEE code info

Public Foundations (T30)

Cancer Research (H30)

Fund Raising and/or Fund Distribution (H12)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2020, 2019 and 2018.
Register now

Communication

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Although significant progress has been made in treating certain forms of cancer since President Richard Nixon signed into legislation The National Cancer Act of 1971, cancer continues to affect one-in-two men, one-in-three women, one-in-four pet dogs and one-in-five cats in the United States alone. For those affected by cancer, progress has not come quickly enough and most new cancer therapies fail to reach the marketplace due to early failure or tremendous cost of development. Companion animals contract naturally-occurring cancers and dogs, in particular, contract cancers similar to pediatric cancers. Animal Cancer Foundation aims to enhance the breakthroughs possible in cancer research by supporting comparative oncology, the study of naturally occurring cancers in our pets that deepens veterinary and human oncology researchers's understanding of these shared cancers.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Canine Cancer Genome Project sponsored by The Blue Buffalo Foundation and Animal Cancer Foundation

The Canine Cancer Genome Project's goal is to map the tumor genomes of the most common canine cancers. Canine tumor genome mapping is a critical step in cancer research.

Population(s) Served
Adults

Annually, ACF awards Comparative Oncology Grant Awards of $50,000 to comparative oncology research teams composed of veterinary and human medical oncologists and bench researchers collaborating on cancer research designed to benefit pets and speed treatment to people with cancer.

Population(s) Served
Adults

These funds support recognized comparative oncology organizations such as the National Institutes of Health - National Cancer Institute Comparative Oncology Tumor Board, or the National Academy of Science, Institute of Medicine in meetings and symposia designed to increase comparative oncology research effectiveness in informing cancer trial development.

Population(s) Served
Adults

Where we work

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

Animal Cancer Foundation's goal is to help speed discovery of breakthrough treatments in the fight against cancer by funding the comparative oncology researchers who are deepening understanding of the common cancers affecting people and pets.

Animal Cancer Foundation is dedicated to funding scientists committed to understanding and sharing the studies that link canine cancer to human cancer through annual grants. Animal Cancer Foundation comparative studies funded have included: Lymphoma and development of canine CAR-T therapy, bladder cancer, osteosarcoma (bone cancer), hemangiosarcoma, melanoma and comparative cancer genomics. A special initiative, The Canine Cancer Genome Project (CCGP) sponsored by the Blue Buffalo Foundation, seeks to map the genetics of the seven most common canine cancers and to place the dataset in the public domain.

Animal Cancer Foundation has provided support to groundbreaking researchers taking us a step closer to discovering effective drug therapies, treatments and an eventual cure, including: Comparative Melanoma Tumor Board, Tufts Cancer Symposium, National Academies of Science-Institute of Medicine Comparative Cancer Workshop and the Veterinary Eastern Cooperative Oncology Group.

Animal Cancer Foundation is composed of a board of directors of business and veterinary oncology leaders whose oversight guides the organization. Scientific Advisory Councils composed of thought leaders in comparative, veterinary and human oncology from multiple institutions are convened to guide the grant selection criteria and processes and to make recommendations for funding to the board of directors. Long-term corporate benefactors such as the Blue Buffalo Foundation, Nationwide Pet and PetValu-US have aligned with Animal Cancer Foundation in making generous gifts to the organization. Various veterinary oncology specialty practices nationwide are supporters of the organization through its memorial donations program, and millions of pet parents have been generous donors, recognizing that our pets are being effected by cancer in great numbers and that discovering new, effective therapies for them will also inform human cancer research.

Animal Cancer Foundation has made annual comparative oncology research grants for the last eight years, with five of those studies being published in prestigious cancer research journals. Three more of those studies are pending publication, demonstrating the quality of selections being made by the scientific advisory council's recommendation to the board of directors.

The Canine Cancer Genome Project (CCGP) sponsored by the Blue Buffalo Foundation is an initiative to map the seven most common canine cancer genomes and to place the datasets in the public domain for use by all cancer researchers. Since pet dogs contract naturally-occurring cancers, since both their lifespans and disease progression are compacted, and since they also share the environment of and similar cancers to people, genetic studies of canine cancers deepen and expand researchers understanding of new targets for effective therapies for people and pets.

Financials

ANIMAL CANCER FOUNDATION
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

ANIMAL CANCER FOUNDATION

Board of directors
as of 6/15/2021
SOURCE: Self-reported by organization
Board chair

Ms. Annie Taylor

ThunderCap, LLC

Term: 2016 - 2018

Gerald Post, DVM, MEM, DACVIM (Oncology)

The Veterinary Cancer Center

Matthew Vuolo, Esq.

Aon

Annie Taylor

Thunder Cap LLC

Jonathan Peris

Merrill Lynch

Jennifer Teitler

MBooth & Associates

Elisa Martin

Medtronic (formerly)

Natasha Lunin

Aon Hewitt

David Levine, MD

Retired

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? No
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? No
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 11/11/2019

Who works and leads organizations that serve our diverse communities? GuideStar partnered on this section with CHANGE Philanthropy and Equity in the Center.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female, Not transgender (cisgender)
Sexual orientation
Decline to state
Disability status
Decline to state

The organization's co-leader identifies as:

No data

Race & ethnicity

No data

Gender identity

No data

 

No data

Sexual orientation

No data

Disability

No data